Curtis Lockshin
Officer at Xenetic Biosciences, Inc. (XBIO)
Curtis Lockshin has filed 9 insider reports with the SEC since March 2021, as director at Phio Pharmaceuticals Corp. (PHIO) and officer at Xenetic Biosciences, Inc. (XBIO). The latest filing, on February 6, 2026, reports grant or award at Phio Pharmaceuticals Corp. (PHIO).
- Filings
- 9
- Companies
- 2
- Bought on market
- None
- Sold on market
- None
Companies where Curtis Lockshin is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 35,155 | $0.7203 | Feb 6, 2026 | ||||
| Officer | $1.53 | Dec 13, 2023 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Feb 5, 2026PHIODirector Lockshin Curtis was granted 16,600 shares, increasing direct ownership by 89% to 35,155 unitsForm 4Grant or award
- Sep 11, 2025PHIODirector Lockshin Curtis was granted 16,200 shares, increasing direct ownership by 688% to 18,555 unitsForm 4Grant or award
- Sep 11, 2024PHIODirector Lockshin Curtis was granted 2,000 sharesForm 4Grant or award
- Dec 11, 2023XBIOSEC Form 4 filed by Lockshin CurtisForm 4Grant or award
- Feb 17, 2023PHIOSEC Form 4: Lockshin Curtis was granted 1,500 shares, increasing direct ownership by 88% to 3,197 unitsForm 4Grant or award
- Mar 24, 2022XBIOSEC Form 4 filed by Lockshin CurtisForm 4Grant or award
- Feb 15, 2022PHIOSEC Form 4: Lockshin Curtis was granted 10,000 shares, increasing direct ownership by 96% to 20,366 unitsForm 4Grant or award
- Mar 18, 2021XBIOSEC Form 4 filed by Curtis LockshinForm 4Grant or award
Compare Curtis Lockshin with
- Curtis Lockshin vs David H Deming1 shared
- Curtis Lockshin vs Ronald Todd Plott1 shared
- Curtis Lockshin vs Robert J Bitterman1 shared
- Curtis Lockshin vs Lisa Cabott Carson1 shared
- Curtis Lockshin vs Patricia A Bradford1 shared
- Curtis Lockshin vs James F Parslow1 shared
Other insiders at the same companies
- David H DemingPHIO
- Ronald Todd PlottPHIO
- Robert J BittermanPHIO
- Lisa Cabott CarsonPHIO
- Patricia A BradfordPHIO
- James F ParslowXBIO
- Jonathan E FreemanPHIO
- Grigory G. BorisenkoXBIO
- Firdaus J. DastoorXBIO
- Roger D. KornbergXBIO
- Alexey Andreevich VinogradovXBIO
- Robert L FerraraPHIO
Questions about Curtis Lockshin
- What is Curtis Lockshin's role at Xenetic Biosciences, Inc.?
- Curtis Lockshin reports to the SEC as officer at Xenetic Biosciences, Inc. (XBIO), according to the latest filing on December 13, 2023. Curtis Lockshin has also filed as director at Phio Pharmaceuticals Corp. (PHIO).
- How many shares does Curtis Lockshin own?
- After the latest filing that states it, Curtis Lockshin directly owned 35,155 shares of Phio Pharmaceuticals Corp. (PHIO). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Curtis Lockshin bought or sold stock recently?
- No open-market purchases or sales by Curtis Lockshin are on file. The filings report grant or award.
- How do I get alerts when Curtis Lockshin files?
- Follow Curtis Lockshin on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Curtis Lockshin (SEC CIK 0001383556). Totals count each trade once, skipping amendments whose original is on file, from Mar 4, 2021 on. View on SEC EDGAR